Impact Coatings AB (publ) (IMPC) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

and welcome to today's webcast with Integrum, where CEO Richard Brodermark, CFO Jörgen Svanström, and US President Jeff Rezani will present a report. After the presentation, there will be a Q&A, so if you have any questions to the company, you can send them in via the form to the right. And with that said, I hand over the word to you guys. Thank you very much, and welcome everyone to Integrum's company presentation, the first quarter of this fiscal year. Next slide, please. so we go directly to the introduction and and so it's the i'm rick deborah one of my accountants founder and ceo and to my left here i have you're looking at monster and on the other side of the pond we have zani u.s president so we we start with a quick recapitulate recapitulation of the company you know we have been uh the real pioneer in bone anchored prosthetics and also into the neuromuscular integrated prosthetics. Our core product is the O-brain implant system, and it is still the only FDA-approved osteointegrated prosthesis for amputees, and currently the approved indication is for above-knee amputees. We have since 2020 had an annual revenue growth of about plus 30%. We have had increasing profitability and we have been trying to scale up the company. We also have a growing pipeline of new products and new indications, such as not only above the knee, also above the elbow, amputations with prosthesis, and we are also working on what we call EO, that is brain control smart prosthesis. We think that we now are well positioned to capitalize on the larger growing global market for advanced perspectives and it's estimated that the market size currently is about 8 billion US dollars. I think we have a proven track record of clinical excellence, scientific innovations and commercial success. We'...